$1.73 Billion is the total value of Woodford Investment Management Ltd's 6 reported holdings in Q3 2015. The portfolio turnover from Q2 2015 to Q3 2015 was 50.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RAI | Buy | REYNOLDS AMERICAN INC | $726,351,000 | +34.7% | 16,407,290 | +127.2% | 41.94% | +1.4% |
| ALKS | Buy | ALKERMES PLC | $305,473,000 | -0.6% | 5,206,633 | +9.0% | 17.64% | -25.2% |
| ABBV | New | ABBVIE INC | $287,165,000 | – | 5,277,800 | +100.0% | 16.58% | – |
| PRTA | Buy | PROTHENA CORP PLC | $281,222,000 | -3.4% | 6,202,525 | +12.2% | 16.24% | -27.3% |
| NWBO | Buy | NORTHWEST BIOTHERAPEUTICS INC | $127,884,000 | -23.0% | 20,461,392 | +22.4% | 7.38% | -42.0% |
| TBPH | New | THERAVANCE BIOPHARMA INC | $3,964,000 | – | 360,685 | +100.0% | 0.23% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2017-05-22
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| PROTHENA CORP PLC | 19 | Q2 2019 | 37.7% |
| ALKERMES PLC | 18 | Q1 2019 | 28.0% |
| THERAVANCE BIOPHARMA INC | 17 | Q3 2019 | 71.3% |
| BIOGEN INC | 12 | Q1 2019 | 9.8% |
| ABBVIE INC | 9 | Q3 2017 | 33.9% |
| NORTHWEST BIOTHERAPEUTICS INC | 9 | Q4 2016 | 12.7% |
| REYNOLDS AMERICAN INC | 7 | Q3 2016 | 45.9% |
| EVOFEM BIOSCIENCES INC | 7 | Q3 2019 | 20.3% |
| AUTOLUS THERAPEUTICS PLC | 6 | Q3 2019 | 33.9% |
| GILEAD SCIENCES INC | 6 | Q4 2017 | 7.6% |
View Woodford Investment Management Ltd's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Evofem Biosciences, Inc.Sold out | February 04, 2020 | 0 | 0.0% |
| Nightstar Therapeutics plcSold out | February 04, 2020 | 0 | 0.0% |
| Theravance Biopharma, Inc. | November 08, 2019 | 429,770 | 0.8% |
| Autolus Therapeutics plc | October 09, 2019 | 2,095,127 | 4.7% |
| NuCana plc | September 09, 2019 | 1,538,000 | 4.8% |
| Prothena Corp plcSold out | September 09, 2019 | 0 | 0.0% |
| NORTHWEST BIOTHERAPEUTICS INC | February 14, 2019 | 24,815,028 | 4.8% |
View Woodford Investment Management Ltd's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2020-02-04 |
| SC 13G/A | 2020-02-04 |
| 13F-HR | 2020-01-27 |
| 13F-HR/A | 2019-11-12 |
| 13F-HR | 2019-11-08 |
| SC 13G/A | 2019-11-08 |
| SC 13G/A | 2019-11-08 |
| SC 13G/A | 2019-10-09 |
| SC 13G/A | 2019-09-09 |
| SC 13G/A | 2019-09-09 |
View Woodford Investment Management Ltd's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.